Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US4781601046
Ticker JNJ
Company JOHNSON & JOHNSON
Currency $
Price
Aware Investor Index (AII) 7.1335
Recommendation BUY
P/E 29.12
ROE 20.83 %
Capitalization 362,480,508,000 $
Dividend Yield 2.66 %
P/S 4.44
AII Position 129
P/E Position 427
ROE Position 154
Capitalization Position 19
Dividend Yield Position 280
Sales 81,581,000,000 $
10-Year Average Earnings 12,448,600,000 $
Shares Outstanding 2,728,700,000
Equity 59,752,000,000 $
Dividend per Share 3.54 $
Industry Personal Care
Country United States
JOHNSON & JOHNSON Investor Relations Web Site http://www.investor.jnj.com/investor-relations.cfm







Sales:

YEAR MONTH AMOUNT
2018 12 81,581,000,000.00 $
2017 12 76,450,000,000.00 $
2016 12 71,890,000,000.00 $
2015 12 70,074,000,000.00 $
2014 12 74,331,000,000.00 $
2013 12 71,312,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 15,297,000,000.00 $
2017 12 1,300,000,000.00 $
2016 12 16,540,000,000.00 $
2015 12 15,409,000,000.00 $
2014 12 16,323,000,000.00 $
2013 12 13,831,000,000.00 $
2012 12 10,514,000,000.00 $
2011 12 9,672,000,000.00 $
2010 12 13,334,000,000.00 $
2009 12 12,266,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 59,752,000,000.00 $
2017 12 60,160,000,000.00 $
2016 12 70,418,000,000.00 $
2015 12 71,150,000,000.00 $
2014 12 69,752,000,000.00 $
2013 12 74,053,000,000.00 $
2012 12 64,826,000,000.00 $
2011 12 57,080,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 2,728,700,000
2017 12 2,745,300,000
2016 12 2,788,900,000
2015 12 2,812,900,000
2014 12 2,863,900,000
2013 12 2,877,000,000
2012 12 2,812,600,000
2011 12 2,775,300,000

 












Bloomberg News for JOHNSON & JOHNSON:



Google News for JOHNSON & JOHNSON:

The Dwinnex - 1 day ago
Johnson & Johnson [JNJ] moving down – What are the long-term ...
Johnson & Johnson [JNJ] is following downward trend in the market concluded with the last trading session. The shares of the Healthcare ...
News Align (press release)
Johnson & Johnson (JNJ) Stock Crashes Following FDA Asbestos ...
Shares of Johnson & Johnson (NYSE:JNJ) plunged on Friday amid reports the consumer healthcare company had recalled some of its baby ...
LedgerTelegraph
Johnson & Johnson: Yield Still Not Worth The Legal Risk
As Johnson & Johnson (NYSE:JNJ) continues to face escalating legal risks, the healthcare company reported sub-par Q3 results promoted as a ...
Stocks Equity (press release)
Don't Overthink It, Buy Johnson & Johnson
Sometimes, I wish I could harken back to the halcyon days of Johnson & Johnson (JNJ) being a relatively boring, steady-eddy, S.W.A.N. stock.
CCN.com - 4 days ago
Johnson & Johnson Stock Rebounds After Earnings
Johnson & Johnson (JNJ) is a diverse health care giant and a component of the Dow Jones Industrial Average. Tuesday morning before the ...
Business Insider
Johnson & Johnson climbs after settling two opioid epidemic ...
Johnson & Johnson shares jumped as much as 3.6% on ... The settlement allows J&J to avoid an October federal trial looking to hold numerous ...
MarketWatch
J&J recalls 33000 bottles of baby powder as FDA finds asbestos in ...
(Reuters) - Johnson & Johnson (JNJ.N) said on Friday it is recalling around 33,000 bottles of baby powder in the United States after U.S. health ...
Motley Fool
Featured Stock:: Johnson & Johnson (JNJ)
Johnson & Johnson (JNJ):. If you are considering getting into the day trading or penny stock market, it's a legitimate and profitable method for ...
Seeking Alpha - 22 hours ago
J&J Faces 100000 More Damage Claims After Taking $8 Billion Hit
Johnson & Johnson has taken some costly beatings in court this year. And it ... Just last week, a jury ordered J&J to pay $8 billion for wrongfully ...
Seeking Alpha - 1 day ago
Johnson & Johnson (JNJ) vs. At EQT Corporation (EQT): Analyzing ...
The shares of Johnson & Johnson have decreased by more than -0.80% this year alone. The shares recently went up by 0.25% or $0.32 and ...


Back